CCTG

@scserendipity1 @yekeduz_emre @OncoAlert @ChrisSweens1 Just out in @EurUrolOncol - information from #ENZAMET @ANZUPtrials @TrialsCentre @cancertrials_ie @CDNCancerTrials @DanaFarber_GU @ChrisSweens1 sciencedirect.com/science/articl…

Established in 2025, these awards support graduate students pursuing MSc or PhD training in the field of cancer research. Open to incoming & current #gradstudents supervised by a @QueensuSCRI faculty member (primary or associate) in a graduate program at @queensu #cancerresearch

#CCTG SC32S survey study opens in Canada, collecting sociodemographic data from clinical trial participants to understand the feasibility of using a survey to gather information about trial participants’ backgrounds and everyday lives. buff.ly/TpK7veq

March is #ColorectalCancerAwarenessMonth & it is the second leading cause of cancer deaths in Canada. Research is so important because when caught early #colorectalcancer is 90% curable.

Blog post from SWOG chairs @DrDawnHershman & @PrimoLaraMD: SWOG Establishes An APP & Nurse Scientist Cmte Our new cmte recognizes the contributions of APPs & nurse scientists & will help empower more of them to contribute to their full scope of practice. swog.org/news-events/ne…

During Multiple Myeloma Awareness Month, the Alliance for Clinical Trials in Oncology and the Alliance Foundation Trials are spotlighting studies designed to improve treatment and term outcomes for this rare blood cancer. bit.ly/Myeloma2026 #MyelomaActionMonth

The #CCTG Annual Spring Meeting is only 6 weeks away! Don't forget that the request an invitation portal closes April 7 and online registration closes April 9. All meeting information is available on the Spring Meeting webpage buff.ly/3Mkm0Gw

#CCTG opens the SC30 study investigating the role of immunoglobulin and antibiotics on infections in patients with blood cancers. Researchers will compare different approaches to preventing infections in people with blood cancers with low antibody levels. buff.ly/vNmoyLl

#CCTG IND Program has launched the Early Clinical Trials Educational Series -Session 2 an Interactive Workshop on Design and Execution of Phase I Trials is coming March 20! JOIN US: buff.ly/Wm4IjV1

TODAY! The Alliance hosts a free webinar on key research from its investigators presented at ASH and SABCS. The virtual event will highlight treatment advances in breast cancer, multiple myeloma, and leukemia. Register: bit.ly/Alliance-Webin… More info: bit.ly/AllianceMar16W…

🔬 STRIVE clinical trial now open in Aotearoa, New Zealand ANZGOG, in partnership with @CDNCancerTrials (CCTG), is pleased to announce the activation of the STRIVE clinical trial in Aotearoa, New Zealand 🇳🇿 STRIVE (ANZGOG2109/2021; CCTG VU.2) represents an important step forward in advancing evidence-based surgical management for women diagnosed with vulvar squamous cell carcinoma (VSCC). VSCC accounts for more than 90% of vulvar cancers and arises via two distinct biological pathways: • HPV-associated • HPV-independent, often linked to lichen sclerosus Emerging evidence suggests these subtypes behave differently, with implications for surgical management and recurrence risk. However, optimal treatment strategies have not been formally tested in a prospective trial. STRIVE is an international, prospective stratification study designed to refine surgical decision-making based on tumour biology, including HPV status and molecular markers such as p53 and dVIN. The trial aims to: • Improve risk stratification • Inform margin assessment • Reduce recurrence rates • Support personalised treatment pathways For HPV-associated tumours, the study will assess whether less extensive surgery can safely reduce complications and improve function without increasing recurrence risk. For HPV-independent tumours, STRIVE will evaluate whether tailored surgical approaches can reduce the likelihood of recurrence where high-risk biological features are present. The first Australasian site at Auckland City Hospital opened on 30 January 2026 and is actively recruiting, with Dr Lois Eva as Principal Investigator. The study is co-chaired in ANZ by Professor Paul Cohen and Dr Lois Eva. Given the relative rarity of vulvar cancer, international collaboration is essential. STRIVE brings together global expertise to generate the evidence needed to strengthen clinical guidelines and improve outcomes for women. 🔗 ClinicalTrials.gov: NCT06358469 More information: anzgog.org.au/strive-trial #ClinicalTrials #GynaecologicalCancer #VulvarCancer #CancerResearch #GlobalCollaboration

A day of insightful discussions & networking in the field of #healthresearch and I-EDIAA. Anna Johnson, EDIIA Lead at @QueensuSCRI CCT division @CDNCancerTrials and SCRI PEN member is one of this year's speakers! More info & registration ⬇️

This incredible @QueensUHealth student-led annual event supports advancing #cancerresearch & patient support programs @QueensuSCRI & our CCT division @CDNCancerTrials all through the #CanadianCancerSociety! Learn how to sign up &/or donate ⬇️ #RelayForLife queensu.ca/gazette/storie…

For unfavourable risk prostate cancer, @CDNCancerTrials #PR24 is accruing and is just about to randomize patient 200!

We agree with you @ChrisSweens1 and thank you for highlighting our work through the NCTN and CCTG! First line mHSPC still has unanswered questions open at your sites ! @ALLIANCE_org @theNCI @CDNCancerTrials @ASCO

CCTG Recognition Awards Nominations 2026 are due by March 2nd honouring individuals who have contributed significantly to the mission and activities of the Group. Don't miss out! ctg.queensu.ca/bulletin/cctg-…

📣 ESMO #ClinicalPracticeGuideline Express Update on Localised #ColonCancer: 💡CHALLENGE trial suggests survival benefits from structured exercise 👥Selected resected patients to be informed & encouraged to participate #Oncology #ESMOGuidelines 🔗 ow.ly/YvrH50Y49aF

@myESMO @GPentheroudakis @LizzySmyth1 This is fantastic news for patients the #CCTG CO.21 trial results have set the standard for non-medical interventions and proves the benefits of a structured exercise program as part of a follow up care.

Today is #WorldCancerDay and #CCTG supports our 2,100 network researchers across Canada conducting the #ClinicalTrials that have a direct impact on improving treatment option for cancer patients @WorldCancerDay #CancerResearch

This is great! @myESMO CPG for localized #ColonCancer updated to include structured #exercise program (SEP)🏃 esmoopen.com/article/S2059-… #ExerciseIsMedicine @CDNCancerTrials 🇨🇦